FDA APPROVES NEW TREATMENT FOR COMPLICATED URINARY TRACT AND COMPLICATED INTRA-ABDOMINAL INFECTIONS

WASHINGTON -- The following information was released by the U.S. Food and Drug Administration (FDA): The U.S. Food and Drug Administration has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial [...]